|
⚲
|
| Keyboard |
| PureTech Health PLC
✚
|
|
|---|---|
| CIK # | 0001782999 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001782999] | |
| 4 | [0001782999] | |
| 6-K | [0001782999] | |
| SC 13D | [0001782999] | |
| SC 13G | [0001782999] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Tang Capital Management LLC | Puretech Health PLC | [2026-04-29] |
| Citigroup Inc | Puretech Health PLC | [2025-08-11] |
| Citigroup Inc | Puretech Health PLC | [2024-11-12] |
| Puretech Health PLC | Akili Inc | [2022-08-30] |
| Invesco Ltd | Puretech Health PLC | [2021-02-16] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| PureTech Health PLC | |
| PureTech LYT Inc | |
| Seaport Therapeutics Inc | |
| PureTech Health LLC | |
| Akili Inc | |
| Gelesis Holdings Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Akili Inc AKLI
Common Stock
|
2024-07-02 | Tender | 12,527,477 | ||
|
Gelesis Holdings Inc GLSH
Convertible Note · derivative
|
2023-09-20 | Buy | $1,500,000.00 | ||
|
Gelesis Holdings Inc GLSH
Convertible Note · derivative
|
2023-06-12 | Buy | $3,000,000.00 | ||
|
Gelesis Holdings Inc GLHS
Warrants · derivative
|
2023-05-26 | Buy | |||
|
Gelesis Holdings Inc GLHS
Convertible Note · derivative
|
2023-05-26 | Buy | 43,133,803 | $350,000.00 | 15,096,831,050,000 |
|
Gelesis Holdings Inc NYSE: GLS
Warrants · derivative
|
2023-05-01 | Buy | 23,688,047 | ||
|
Gelesis Holdings Inc NYSE: GLS
Convertible Note · derivative
|
2023-05-01 | Buy | 5,000,000 | $5,000,000.00 | 25,000,000,000,000 |
|
Gelesis Holdings Inc NYSE: GLS
Convertible Note · derivative
|
2023-05-01 | Buy | 2,000,000 | $2,000,000.00 | 4,000,000,000,000 |
|
Gelesis Holdings Inc NYSE: GLS
Warrants · derivative
|
2023-05-01 | Buy | 192,307,692 |